DelMar Pharmaceuticals Presents Poster at AACR’s Ovarian Cancer Special Conference on the Mechanistic Rationale for VAL-083 Overcoming Treatment Resistance in Ovarian Cancer Oct 3, 2017
RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Oct 3, 2017
RedHill Biopharma Accelerates RHB-104 Phase III Study in Crohn’s Disease with Top-Line Results Expected Mid-2018 Oct 2, 2017
Preferred Dental Technologies Inc. (“Company”) (CSE: PDT): Preferred Dental Implant Corp. announces EAS product now ready for sale, additional R&D initiatives nearing completion Oct 2, 2017
Future Farm Bringing Augmented Reality to the Cannabis Industry Under Exclusive License to Patented IP Sep 29, 2017
CEO Jeffery Bacha Discusses DelMar’s VOL-083 Clinical Trials and the Major Milestones Ahead Sep 26, 2017
First Global Partners to Facilitate Payments for Chinese Vacationers and Overseas Students Sep 26, 2017
Preferred Dental Technologies Completes Initial Order of its Unique 4-Part Solution for a Dental Implant Mounting System Sep 26, 2017
Preferred Dental announces initial product order complete, outlines future initiatives being undertaken Sep 25, 2017
Regulus Intersects 523.9 Metres with 0.65% Cu, 0.47 G/T Au and 7.9 G/T Ag at AntaKori Project, Peru Sep 25, 2017
